Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-26

Clinical Trial Update: Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Rituximab plus chemotherapy, with or without radiation therapy, in patients with B-cell non-Hodgkin lymphoma; trial completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)

Snippet

Sponsor: German High-Grade Non-Hodgkin's Lymphoma Study Group | Conditions: Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2025-08-26